1159840-61-5 | 1H-Imidazo[4,5-c]quinoline-1-ethanol, 4-amino-2-[(ethylamino)methyl]-α,α-dimethyl-, 2,2,2-trifluoroacetate (1:2)

Packsize	Purity	Availability	Price	Discounted Price
1mg	98%	in stock	$28.00	$19.00
5mg	98%	in stock	$58.00	$40.00
10mg	98%	in stock	$90.00	$63.00
25mg	98%	in stock	$158.00	$110.00
50mg	98%	in stock	$268.00	$187.00

Description

• Catalog Number: AB53625
• Chemical Name: 1H-Imidazo[4,5-c]quinoline-1-ethanol, 4-amino-2-[(ethylamino)methyl]-α,α-dimethyl-, 2,2,2-trifluoroacetate (1:2)
• CAS Number: 1159840-61-5
• Molecular Formula: C21H25F6N5O5
• Molecular Weight: 541.4441
• MDL Number: MFCD31619251
• SMILES: OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CCNCc1nc2c(n1CC(O)(C)C)c1ccccc1nc2N

Upstream Synthesis Route

The compound 1H-Imidazo[4,5-c]quinoline-1-ethanol, 4-amino-2-[(ethylamino)methyl]-α,α-dimethyl-, 2,2,2-trifluoroacetate (1:2) has significant applications in chemical synthesis, particularly in the pharmaceutical industry. This compound serves as a versatile building block in the synthesis of various pharmaceutical agents and drug candidates.Due to its unique chemical structure and reactivity, this compound can be used as a key intermediate in the preparation of novel pharmaceutical compounds. Its incorporation into molecular frameworks can impart desirable pharmacological properties or enhance biological activity. Additionally, the presence of functional groups in this compound allows for further derivatization, leading to the development of structurally diverse molecules with potential therapeutic benefits.In chemical synthesis, this compound can participate in a variety of reactions such as nucleophilic substitutions, condensations, and catalytic transformations to construct complex molecular architectures. Its trifluoroacetate salt form provides enhanced solubility and stability, making it a valuable reagent in synthetic organic chemistry.Overall, the use of 1H-Imidazo[4,5-c]quinoline-1-ethanol, 4-amino-2-[(ethylamino)methyl]-α,α-dimethyl-, 2,2,2-trifluoroacetate (1:2) in chemical synthesis offers a strategic approach towards the development of new chemical entities with potential pharmaceutical applications.